Interim & special projects management (integration of acquired company, implementation IBP, improvement procurement)

Beschaffung 

Einkauf

Supply Chain Management 

Sales & Operations Planning - S&OP

Projektleitung

Assumed key accountability for directing global Unit Strategic Forecast (USF) for small & large molecules, biologics, OTC, and consumers, incl. launch products in line with commercial Long Range Financial Plan and clinical demand to secure future (10 years) internal supply network and external contractors (CMO) success, and to improve performance across the supply network.

• Credited with improving global & local digital forecast processes e2e, forecast accuracy & forecast assumptions, and keeping all deadlines despite a global reorganisation in 2019. Mastered and addressed reports with relevant senior leaders.
• Increased operational effectiveness and efficiency by redesigning the entire forecast software, reducing workload by 50%.
• Co-Leader and clean sheeted for global strategic supply chain network optimisation and scaling projects.
• Led and introduced tender volumes, loss of exclusivity (LoE) and potential upsides into the strategic forecast & supply plan.
• Baseline for the strategic network & capacity management for all internal sites and contractors CMOs (make vs buy).

Served as customer management representative to effectively shape and execute all aspects of global demand & affiliate supply management, unit strategic forecasting, regional account management, and business excellence for Actelion integration project, a large acquisition. Actelion treats rare diseases for individuals with Pulmonary Arterial Hypertension (PAH).

• Designed & presented SC concepts (M&A) with low-cost implementation plan to senior leaders, accepted & implemented.
• Led a global virtual project team of experts working in various functions to integrate and transform Actelion.
• Conducted and chaired regular cross-functional project meetings with commercial operation PAH, tax, finance, supply, launch, production, business development, digital (ERP/SAP), regulatory affairs, logistics, 3PL, and quality to assure timely completion.

Led high performing team of global pharmaceutical demand management (DM) to support commercial & clinical partners (entire portfolio, all APIs) and provide high-quality forecast figures and demand assumptions by using innovative, digital & lean approaches. Oversaw the execution of all strategies and initiatives of demand planning (SAP APO DP) to drive continuous improvement. Spearheaded DM Center of Excellence (CoE) team, which acted as the global single point of contact for pharmaceutical in market demand data.

• Successfully reduced 36 months rolling forecast accuracy (MAPE) from 33.7% (Apr 2014) to top quartile world class 15.4% (April 2018), with a global BIAS of approx. 5-6%., becoming a benchmark demand team within Johnson & Johnson.
• Saved $ 18 million safety stock per year and $ 90 million over five years by DM CoE team for all brands / franchises.
• Conducted the successful implementation of Demand Planning (DP) Playbook (blueprint) in all regions and affiliates, covering all stages of the product life cycle to further improve end-to-end planning, including Vendor Management (VMI) & simulations.
• Supported product retention team with statistical forecast models. Pioneered new low-cost processes and introduced several projects like Tracking Signal, DP Centralisation and DP Champions, Vendor Management, and Community of Practice (CoP).
• Introduced robust tender process globally, mitigate supply risk & reduce obsolescence. Optimised SAP APO with 80+ markets and regions and increased visibility and transparency including product launch, tender and LoE for all key stakeholders.
• Co-lead of the new global product launch process to enhance transparency along the supply chain including relevant functions (commercial, regulatory, clinical, etc.) to better understand launch assumptions, risks, and opportunities.
• First results with digital Artificial Neural Network (ANN) are outstanding and exceed consensus demand & traditional statistics.

Streamlined regional S&OP / IBP process and steered the deployment of demand, supply and inventory planning to support systems solutions, aiming at improving overall business planning. Built and strengthened key working partnerships with supply chain stakeholders across all 30 European markets, 10 operating units, and over 100 third party suppliers to drive common business processes across the organisation and enhance cross-enterprise integration. Supervised supply chain operations (Iceland, Malta and Indonesia to Europe) and implemented appropriate planning parameters (MOQs, safety stocks, lead times, frozen periods, RCCP).

• Mastered 750+ APIs, 28?000+ SKUs within Generics, OTC, and Oncology in a fast moving business environment.
• Balanced 3 Operations (Iceland, Malta & Jakarta) with 30 European markets.
• Reduced stock levels, ? 40 M, in the markets by year end by reconciling demand, supply, inventory, and sourcing.
• Recognised for introducing full cycle S&OP process at the headquarters, involving relevant stakeholders like commercial (sales and marketing), finance, business intelligence (BI), procurement, development, tender, product launch, operations, and clinical resulting in identifying new cost saving opportunities along the entire supply chain.
• Credited with implementing new tools for root cause investigation and performance reporting.

Engaged with suppliers and affiliates, commercial, clinical, operations, procurement, quality, and regulatory affairs representatives to ensure the successful implementation of Sales and Operations Planning (S&OP) and Integrated Business Planning (IBP) to balance the entire supply chain end-to-end (rough cut capacity planning). Headed all facets of life cycle management, demand assumptions, forecast, and supply management, and inventory management / governance, reconciliation and executive management. Identified product margin improvements and cost reduction opportunities.

• Modelled, designed, and deployed S&OP / IBP, including finance globally, resulting in delaying a large facility investment for three years due to strategic demand and supply knowledge, enhancing customer service level to >99.5% in a double-digit growing company, reducing affiliate stock level by 25% in Europe / by 45% in the USA, dropping of obsolescence cost by over 50%, and increasing the overall gross margin by 4-5%.
• Facilitated supply & production planning (MPS / MRP / BOM) following dependent / independent category demand.
• Designed, negotiated & outsourced of GDP services to third-party logistics (3PLs) within a Europe-wide distributor network.
• Optimised production planning and scheduling to improve overall supply & distribution performance.
• Introduced a robust process for both, launches and delisting's with R&D, validation, and manufacturing (MFG).
• Set direction and build-up of resources and capacity for the ten-year strategic horizon (internal and external).
• Conducted postponement strategy (finish-to-order to reduce number of variants) by delaying final assembly.

Responsible for all corporate purchasing & contracting for the three business units and strategic sourcing in line with company policy and supplier agreements. Manage suppliers / contractors according to new Corporate Standards and supervise Warehouses.

• Purchase of pharmaceutical finished products, bulk, chemistry, active pharmaceutical ingredients (API), chemicals, raw material, and excipients, including packaging material, traceability, CAPEX, OPEX and invoice review & accounts payable.
• Define, segment, develop and implement more efficient and effective value streams in purchasing, customer service, contractors (CMO), and warehouse & distribution centre (DC) as well as its master data.
• Supervise the Procurement / Sourcing Department and the Warehouses and stream ERP/ MPS / MRP - system.
• Facilitate all artwork changes for primary & secondary packaging, and synchronise with regulatory affairs, quality affairs, commercial, marketing, operations, manufacturing (MFG), procurement, packaging and suppliers, including validation.
• Handling of goods receipt and shipped, including documentations.
• Execute to outsource of finished products to contractors (CMOs) together with regulatory affairs, operations, validation, quality assurance, and commercial & marketing.
• Work and negotiate intensively with contract partners (CMOs).
• Responsible for contractor performance, development, audits and effective relationship.
• Identify product margin improvements and cost reduction opportunities.
• Facilitate and establish GMP-documentations (SOPs).
• GMP-Audit experience with FDA, TÜV, Dekra and SGS.